Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Nov. 7];4(6):s102. Available from: https://skin.dermsquared.com/skin/article/view/1079